Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1995 Jun;69(6):3358–3368. doi: 10.1128/jvi.69.6.3358-3368.1995

Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection.

M C Jung 1, H M Diepolder 1, U Spengler 1, E A Wierenga 1, R Zachoval 1, R M Hoffmann 1, D Eichenlaub 1, G Frösner 1, H Will 1, G R Pape 1
PMCID: PMC189048  PMID: 7538172

Abstract

Overcoming hepatitis B virus infection essentially depends on the appropriate immune response of the infected host. Among the hepatitis B virus antigens, the core (HBcAg) and e (HBeAg) proteins appear highly immunogenic and induce important lymphocyte effector functions. In order to investigate the importance of HBcAg/HBeAg-specific T lymphocytes in patients with acute and chronic hepatitis B and to identify immunodominant epitopes within the HBcAg/HBeAg, CD4+ T-cell responses to hepatitis B virus-encoded HBcAg and HBcAg/HBeAg-derived peptides were studied in 49 patients with acute and 39 patients with chronic hepatitis B. The results show a frequent antigen-specific CD4+ T-cell activation during acute hepatitis B infection, a rare HBcAg/HBeAg-specific CD4+ T-cell response among HBeAg+ chronic carriers, and no response in patients with anti-HBe+ chronic hepatitis. An increasing CD4+ T-cell response to HBcAg/HBeAg coincides with loss of HBeAg and hepatitis B virus surface antigen (HBsAg). Functional analysis of peptide-specific CD4+ T-cell clones revealed a heterogeneous population with respect to lymphokine production. Epitope mapping within the HBcAg/HBeAg peptide defined amino acids (aa) 1 to 25 and aa 61 to 85, irrespective of the HLA haplotype, as the predominant CD4+ T-cell recognition sites. Other important sequences could be identified in the amino-terminal part of the protein, aa 21 to 45, aa 41 to 65, and aa 81 to 105. The immunodominant epitopes are expressed in both proteins, HBcAg and HBeAg. Our findings lead to the conclusion that activation of CD4+ T lymphocytes by HBcAg/HBeAg is a prerequisite for viral elimination, and further studies have to focus on the question of how to enhance or induce this type of T-cell response in chronic carriers. The immunodominant viral sequences identified may have relevance to synthetic vaccine design and to the use of peptide T-cell sites as immunotherapeutic agents in chronic infection.

Full Text

The Full Text of this article is available as a PDF (474.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertoletti A., Ferrari C., Fiaccadori F., Penna A., Margolskee R., Schlicht H. J., Fowler P., Guilhot S., Chisari F. V. HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10445–10449. doi: 10.1073/pnas.88.23.10445. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bottomly K. A functional dichotomy in CD4+ T lymphocytes. Immunol Today. 1988 Sep;9(9):268–274. doi: 10.1016/0167-5699(88)91308-4. [DOI] [PubMed] [Google Scholar]
  3. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  4. Clerici M., Shearer G. M. A TH1-->TH2 switch is a critical step in the etiology of HIV infection. Immunol Today. 1993 Mar;14(3):107–111. doi: 10.1016/0167-5699(93)90208-3. [DOI] [PubMed] [Google Scholar]
  5. Evavold B. D., Sloan-Lancaster J., Allen P. M. Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands. Immunol Today. 1993 Dec;14(12):602–609. doi: 10.1016/0167-5699(93)90200-5. [DOI] [PubMed] [Google Scholar]
  6. Ferrari C., Bertoletti A., Penna A., Cavalli A., Valli A., Missale G., Pilli M., Fowler P., Giuberti T., Chisari F. V. Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J Clin Invest. 1991 Jul;88(1):214–222. doi: 10.1172/JCI115280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ferrari C., Penna A., Bertoletti A., Valli A., Antoni A. D., Giuberti T., Cavalli A., Petit M. A., Fiaccadori F. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol. 1990 Nov 15;145(10):3442–3449. [PubMed] [Google Scholar]
  8. Ferrari C., Penna A., DegliAntoni A., Fiaccadori F. Cellular immune response to hepatitis B virus antigens. An overview. J Hepatol. 1988 Aug;7(1):21–33. doi: 10.1016/s0168-8278(88)80503-8. [DOI] [PubMed] [Google Scholar]
  9. Hsu H. Y., Chang M. H., Hsieh K. H., Lee C. Y., Lin H. H., Hwang L. H., Chen P. J., Chen D. S. Cellular immune response to HBcAg in mother-to-infant transmission of hepatitis B virus. Hepatology. 1992 May;15(5):770–776. doi: 10.1002/hep.1840150505. [DOI] [PubMed] [Google Scholar]
  10. Jean-Jean O., Levrero M., Will H., Perricaudet M., Rossignol J. M. Expression mechanism of the hepatitis B virus (HBV) C gene and biosynthesis of HBe antigen. Virology. 1989 May;170(1):99–106. doi: 10.1016/0042-6822(89)90356-5. [DOI] [PubMed] [Google Scholar]
  11. Jung M. C., Spengler U., Schraut W., Hoffmann R., Zachoval R., Eisenburg J., Eichenlaub D., Riethmüller G., Paumgartner G., Ziegler-Heitbrock H. W. Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B. J Hepatol. 1991 Nov;13(3):310–317. doi: 10.1016/0168-8278(91)90074-l. [DOI] [PubMed] [Google Scholar]
  12. Lau J. Y., Wright T. L. Molecular virology and pathogenesis of hepatitis B. Lancet. 1993 Nov 27;342(8883):1335–1340. doi: 10.1016/0140-6736(93)92249-s. [DOI] [PubMed] [Google Scholar]
  13. Liu Z., Williams K. P., Chang Y. H., Smith J. A. Immunodominance: a single amino acid substitution within an antigenic site alters intramolecular selection of T cell determinants. J Immunol. 1993 Aug 15;151(4):1852–1858. [PubMed] [Google Scholar]
  14. Maruyama T., Iino S., Koike K., Yasuda K., Milich D. R. Serology of acute exacerbation in chronic hepatitis B virus infection. Gastroenterology. 1993 Oct;105(4):1141–1151. doi: 10.1016/0016-5085(93)90960-k. [DOI] [PubMed] [Google Scholar]
  15. Maruyama T., Iino S., Koike K., Yasuda K., Milich D. R. Serology of acute exacerbation in chronic hepatitis B virus infection. Gastroenterology. 1993 Oct;105(4):1141–1151. doi: 10.1016/0016-5085(93)90960-k. [DOI] [PubMed] [Google Scholar]
  16. Maruyama T., McLachlan A., Iino S., Koike K., Kurokawa K., Milich D. R. The serology of chronic hepatitis B infection revisited. J Clin Invest. 1993 Jun;91(6):2586–2595. doi: 10.1172/JCI116497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. McNamee L. A., Fattah D. I., Baker T. J., Bains S. K., Hissey P. H. Production, characterisation and use of monoclonal antibodies to human interleukin-5 in an enzyme-linked immunosorbent assay. J Immunol Methods. 1991 Jul 26;141(1):81–88. doi: 10.1016/0022-1759(91)90212-x. [DOI] [PubMed] [Google Scholar]
  18. Milich D. R. Immune response to hepatitis B virus proteins: relevance of the murine model. Semin Liver Dis. 1991 May;11(2):93–112. doi: 10.1055/s-2008-1040428. [DOI] [PubMed] [Google Scholar]
  19. Milich D. R., McLachlan A. The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen. Science. 1986 Dec 12;234(4782):1398–1401. doi: 10.1126/science.3491425. [DOI] [PubMed] [Google Scholar]
  20. Milich D. R., McLachlan A., Thornton G. B., Hughes J. L. Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site. Nature. 1987 Oct 8;329(6139):547–549. doi: 10.1038/329547a0. [DOI] [PubMed] [Google Scholar]
  21. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986 Apr 1;136(7):2348–2357. [PubMed] [Google Scholar]
  22. Pasek M., Goto T., Gilbert W., Zink B., Schaller H., MacKay P., Leadbetter G., Murray K. Hepatitis B virus genes and their expression in E. coli. Nature. 1979 Dec 6;282(5739):575–579. doi: 10.1038/282575a0. [DOI] [PubMed] [Google Scholar]
  23. Raimondo G., Schneider R., Stemler M., Smedile V., Rodino G., Will H. A new hepatitis B virus variant in a chronic carrier with multiple episodes of viral reactivation and acute hepatitis. Virology. 1990 Nov;179(1):64–68. doi: 10.1016/0042-6822(90)90274-u. [DOI] [PubMed] [Google Scholar]
  24. Rötzschke O., Falk K. Origin, structure and motifs of naturally processed MHC class II ligands. Curr Opin Immunol. 1994 Feb;6(1):45–51. doi: 10.1016/0952-7915(94)90032-9. [DOI] [PubMed] [Google Scholar]
  25. Scott P. Selective differentiation of CD4+ T helper cell subsets. Curr Opin Immunol. 1993 Jun;5(3):391–397. doi: 10.1016/0952-7915(93)90058-z. [DOI] [PubMed] [Google Scholar]
  26. Sylvan S. P. Cellular immune responses to hepatitis B virus antigens in man. Liver. 1991 Feb;11(1):1–23. doi: 10.1111/j.1600-0676.1991.tb00485.x. [DOI] [PubMed] [Google Scholar]
  27. Tsai S. L., Chen P. J., Lai M. Y., Yang P. M., Sung J. L., Huang J. H., Hwang L. H., Chang T. H., Chen D. S. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. J Clin Invest. 1992 Jan;89(1):87–96. doi: 10.1172/JCI115590. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Van der Meide P. H., Dubbeld M., Schellekens H. Monoclonal antibodies to human immune interferon and their use in a sensitive solid-phase ELISA. J Immunol Methods. 1985 May 23;79(2):293–305. doi: 10.1016/0022-1759(85)90109-7. [DOI] [PubMed] [Google Scholar]
  29. Van der Pouw-Kraan T., Van Kooten C., Rensink I., Aarden L. Interleukin (IL)-4 production by human T cells: differential regulation of IL-4 vs. IL-2 production. Eur J Immunol. 1992 May;22(5):1237–1241. doi: 10.1002/eji.1830220519. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES